REVAPP
Mark Identification

REVAPP

Serial Number

87235575

Filing Date

Nov 14, 2016

Trademark by

CELGENE CORPORATION

Classification Information

Computer application software for mobile phones, portable media players, handheld computers, namely, software for use in database management, for use in electronic storage of data, for use as a spreadsheet, and for word processing, all for use by patients and health care professionals in connection with providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide; downloadable software in the nature of a mobile application for use in database management, for use as a spreadsheet, for word processing, for electronic storage of data, in connection with providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide; computer software for use on mobile and cellular phones in the field of health care and dosing of pharmaceuticals for use in accessing databases and websites in order to provide drug dosage and administration information in the field of lenalidomide; downloadable electronic software for use on mobile and cellular phones, handheld computers in the field of health care and dosing of pharmaceuticals for use in accessing databases and websites in order to provide drug dosage and administration information in the field of lenalidomide; computer application software for mobile phones, portable media players, handheld computers, namely, software for use in database management, for use in electronic storage of data, for use as a spreadsheet, and for word processing, all for use by patients and health care professionals in connection with providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide

Electrical and Scientific Apparatus

Software as a service (SAAS) featuring software for tracking and monitoring, all for use by patients and health care professionals in connection with providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide; providing information about the results of clinical trials for pharmaceutical products; providing temporary use of non downloable online software applications containing information on the use of pharmaceutical products and for calculating use of medicine in the field of lenalidomide and safety issues pertaining to lenalidomide; providing temporary use of non-downloadable electronic software for use on mobile and cellular phones, handheld computers in the field of health care and dosing of pharmaceuticals for use in accessing databases and websites in order to provide drug dosage and administration information in the field of lenalidomide and safety issues pertaining to lenalidomide; non-downloadable computer application software for mobile phones, portable media players, handheld computers, namely, software for use in database management, for use in electronic storage of data, for use as a spreadsheet, and for word processing, all for use by patients and health care professionals in connection with providing medical counseling and medical information in the field of lenalidomide and safety issues pertaining to lenalidomide

Computer and Scientific